Top European Penny Stocks To Watch In January 2026

As the pan-European STOXX Europe 600 Index reaches new heights, buoyed by an improving economic backdrop, investors are keenly observing opportunities across various market segments. Penny stocks, although a somewhat outdated term, remain relevant as they often represent smaller or newer companies with potential for growth. By focusing on penny stocks with strong financial health and clear growth trajectories, investors can uncover promising opportunities in Europe's diverse market landscape.

Top 10 Penny Stocks In Europe

Name	Share Price	Market Cap	Rewards & Risks
Ariston Holding (BIT:ARIS)	€4.438	€1.54B	✅ 4 ⚠️ 3 View Analysis >
Orthex Oyj (HLSE:ORTHEX)	€4.79	€85.06M	✅ 4 ⚠️ 1 View Analysis >
Angler Gaming (NGM:ANGL)	SEK3.60	SEK269.95M	✅ 4 ⚠️ 2 View Analysis >
Angler Gaming (DB:0QM)	€0.31	€226.45M	✅ 3 ⚠️ 3 View Analysis >
Libertas 7 (BME:LIB)	€3.30	€70M	✅ 3 ⚠️ 3 View Analysis >
Hultstrom Group (OM:HULT B)	SEK3.14	SEK191.03M	✅ 2 ⚠️ 2 View Analysis >
ForFarmers (ENXTAM:FFARM)	€4.59	€405.69M	✅ 4 ⚠️ 1 View Analysis >
Deceuninck (ENXTBR:DECB)	€2.265	€313.07M	✅ 4 ⚠️ 1 View Analysis >
Dovre Group (HLSE:DOV1V)	€0.0726	€7.89M	✅ 2 ⚠️ 3 View Analysis >
Netgem (ENXTPA:ALNTG)	€0.794	€26.59M	✅ 2 ⚠️ 2 View Analysis >

Click here to see the full list of 285 stocks from our European Penny Stocks screener.

Let's review some notable picks from our screened stocks.

BigRep (DB:B1GR)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: BigRep SE is a company that produces 3D printing solutions across Germany, the United States, and Singapore, with a market cap of €9.29 million.

Operations: The company generates its revenue from Printers & Related Products, amounting to €7.92 million.

Market Cap: €9.29M

BigRep SE, with a market cap of €9.29 million, faces significant challenges as its auditor has expressed doubts about its ability to continue as a going concern. The company remains unprofitable and has seen a substantial decline in revenue by 71.2% over the past year, yet it maintains short-term asset coverage over liabilities and satisfactory net debt to equity ratios at 30.1%. Despite trading well below fair value estimates, BigRep's high volatility and inexperienced board may present risks for investors seeking stability in penny stocks within the European market.

• Click here and access our complete financial health analysis report to understand the dynamics of BigRep.
• Gain insights into BigRep's past trends and performance with our report on the company's historical track record.

Otovo (OB:OTOVO)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Otovo ASA operates an online marketplace for solar installations in Norway and has a market cap of NOK320.36 million.

Operations: The company generates revenue primarily from its B2C segment, amounting to NOK629.96 million.

Market Cap: NOK320.36M

Otovo ASA, with a market cap of NOK320.36 million, presents both opportunities and challenges in the penny stock space. Recent board changes could signal strategic shifts as it navigates its unprofitable status, though it has managed to raise additional capital through equity offerings. The company reported a revenue of NOK629.96 million from its B2C segment but continues to face short-term cash runway issues despite having more cash than debt and covering liabilities with assets. Otovo's stock remains volatile, yet trades at good value compared to peers, offering potential for investors willing to tolerate risk in pursuit of growth prospects.

• Unlock comprehensive insights into our analysis of Otovo stock in this financial health report.
• Gain insights into Otovo's outlook and expected performance with our report on the company's earnings estimates.

Dr. Miele Cosmed Group (WSE:DMG)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Dr. Miele Cosmed Group S.A. is involved in the production and sale of chemical and cosmetic products both in Poland and internationally, with a market cap of PLN252.41 million.

Operations: The company's revenue is primarily generated from the production of cosmetic, toilet, and household chemistry products, totaling PLN501.04 million.

Market Cap: PLN252.41M

Dr. Miele Cosmed Group S.A., with a market cap of PLN252.41 million, offers a mixed picture for penny stock investors. The company reported Q3 2025 revenue of PLN131.61 million, slightly down from the previous year, and net income decreased to PLN5.78 million from PLN12.13 million. Despite being undervalued by 38.5% compared to fair value estimates, challenges include declining profit margins and negative earnings growth over the past year (-32.7%). Positively, its debt is well managed with operating cash flow covering debt obligations effectively, and short-term assets exceeding liabilities provide some financial stability amidst volatility concerns.

• Click to explore a detailed breakdown of our findings in Dr. Miele Cosmed Group's financial health report.
• Explore historical data to track Dr. Miele Cosmed Group's performance over time in our past results report.

Turning Ideas Into Actions

• Reveal the 285 hidden gems among our European Penny Stocks screener with a single click here.
• Looking For Alternative Opportunities? Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com